Alcidion Group (ASX:ALC) signed a AU$5.5 million annual recurring subscription license contract with the Hywel Dda University Health Board in Wales for the use of its Miya Precision platform, according to a Tuesday Australian bourse filing.
The university health board will use Miya Precision for patient flow, observations and assessments, as well as a Smartpage for clinical communications and tasking.
The contract will last over five years, with an option to further extend for seven years for a total contract value of AU$7.7 million.
The company's shares rose past 5% in recent trading on Tuesday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.